BackArrowhead Pharmaceuticals Overview

Arrowhead Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ARWR.

Quarterly EBIT

-$141.26M
↓ 136.1% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$214.41M
↓ 135.21% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin